NCT00824187View on ClinicalTrials.gov

YAZ Premenstrual Dysphoric Disorder (PMDD) in China

PHASE3CompletedINTERVENTIONAL
Enrollment

187

Participants

Timeline

Start Date

January 31, 2009

Primary Completion Date

January 31, 2011

Study Completion Date

January 31, 2011

Conditions
Premenstrual Dysphoric Disorder ( PMDD)
Interventions
DRUG

EE20/DRSP(YAZ, BAY86-5300)

20 μg ethinylestradiol, 3mg drospirenone, tablet, orally, opd

DRUG

Placebo

Inert tablet

Trial Locations (16)

100050

Beijing

100191

Beijing

100853

Beijing

116011

Dalian

210029

Nanjing

250012

Jinan

300193

Tianjin

310003

Hangzhou

410011

Changsha

430060

Wuhan

510405

Guangzhou

510630

Guangzhou

610041

Chengdu

650032

Kunming

710032

Xi’an

710061

Xi’an

Sponsors

Lead Sponsor

Bayer
All Listed Sponsors
lead

Bayer

INDUSTRY